Try our Advanced Search for more refined results

Analysis

IP, Pharma Groups Call For Patent Eligibility Law Overhaul

By Ryan Davis ( January 30, 2017, 8:51 PM EST) -- Citing the confusion caused by recent court rulings on patent-eligibility, major intellectual property and pharmaceutical industry groups have suggested to the U.S. Patent and Trademark Office that the time has come for Congress to rewrite the law on what can and cannot be patented....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!